|
|
||||||||||||||||||
|
|
||||||||||||||||||
|
||||||||||||||||||||
PerCP contained in this product is protected by patents owned by Becton, Dickinson & Company (European patent 0314406, or Japanese Patent JP1888759). This product will not be sold or shipped to customers in France, Germany, Italy, United Kingdom or Japan until the pertinent patents are no longer in effect (October 21, 2008). Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe N418 monoclonal antibody reacts with mouse CD11c, the integrin αX. CD11c non-covalently associates with β2 integrin to form the CD11c/CD18 heterodimer. CD11c is expressed by dendritic cells, a subset of Intestinal Intraepithelial Lymphocytes (IEL) and some activated T cells. CD11c/CD18 binds to CD54, iC3b and fibrinogen and plays a role in leukocyte adhesive interactions. N418 binds to CD11c on splenic dendritic cells in the T-dependent areas of mouse spleen and precipitates a 150, 90 kDa heterodimer. Applications ReportedFor research use only, not for diagnostic or therapeutic use. This N418 antibody has been reported for use in flow cytometric analysis. Applications TestedThis N418 antibody has been tested by flow cytometric analysis of mouse splenocytes. This can be used at less than or equal to 0.25 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Crowley MT, Inaba K, Witmer-Pack MD, Gezelter S, Steinman RM. 1990. Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen. J Immunol Methods. 133:55-66. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med. 171:1753-71. Esche C, Gambotto A, Satoh Y, Gerein V, Robbins PD, Watkins SC, Lotze MT, Shurin MR. 1999. CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth. Eur J Immunol. 29:2148-55. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol. 157:1406-14. Related ProductsCat. 45-4888 PerCP-Cy5.5 Armenian Hamster IgG Isotype Control (clone eBio299Arm) |
||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |